Long Remission in Muscle-Specific Kinase Antibody-Positive Juvenile Myasthenia

Pediatric Neurology

Volumn 40, Issue 6, 2009, Pages 455-456

  Anlar, Banu ^a   Yilmaz, Vuslat ^b   Saruhan Direskeneli, Güher ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; ENZYME ANTIBODY; IMMUNOGLOBULIN; MUSCLE SPECIFIC KINASE ANTIBODY; PREDNISONE; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; BULBAR PARALYSIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; IMMUNOMODULATION; MALE; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; PTOSIS; RELAPSE; REMISSION; TREATMENT RESPONSE; WEAKNESS;

ANTIBODIES; CHILD; HUMANS; MALE; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; RECURRENCE;

EID: 65449136244     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2008.11.014     Document Type: Article

References (11)

1. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., and Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7 (2001) 365-368
2. Plested C.P., Tang T., Spreadbury I., Littleton E.T., Kishore U., and Vincent A. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG. Neurology 59 (2002) 1682-1688
3. Anlar B., and Vincent A. Antibodies against muscle-specific kinase in juvenile myasthenia gravis. Neuropediatrics 34 (2003) 110-111
4. Farrugia M.E., Robson M.D., Clover L., et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 129 (2006) 1481-1492
5. Evoli A., Tonali P.A., Padua L., et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126 (2003) 2304-2311
6. Murai H., Noda T., Himeno E., et al. Infantile onset myasthenia gravis with MuSK antibodies. Neurology 67 (2006) 174
7. Sanders D.B., El-Salem K., Massey J.M., McConville J., and Vincent A. Clinical aspects of MuSK antibody positive seronegative myasthenia gravis. Neurology 60 (2003) 1978-1980
8. Caress J.B., Hunt C.H., and Batish S.D. Anti-MuSK myasthenia gravis presenting with purely ocular findings. Arch Neurol 62 (2005) 1002-1003
9. Ohta K., Shigemoto K., Fujinami A., Maruyama N., Konishi T., and Ohta M. Clinical and experimental features of MuSK antibody positive MG in Japan. Eur J Neurol 14 (2007) 1029-1034
10. Yeh J.H., Chen W.H., Chiu H.C., and Bai C.H. MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis. J Neurol Sci 263 (2007) 191-193
11. Farrugia M.E., Robson M.D., Clover L., et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 129 (2006) 1481-1492